Filtered By:
Drug: Rituxan
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 7090 results found since Jan 2013.
Neutropenia following Rituximab in paediatric non-malignant diseases: case series and review of the literature
Singapore Med J. 2021 Nov 8. doi: 10.11622/smedj.2021188. Online ahead of print.NO ABSTRACTPMID:34749497 | DOI:10.11622/smedj.2021188
Source: Singapore Medical Journal - November 9, 2021 Category: General Medicine Authors: Zhi Rui Samuel Lim Kai Liang Teh Lena Das Thaschawee Arkachaisri Source Type: research
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
CONCLUSION: In the last decade, the outcome of newly diagnosed MCL patients improved. ASCT in the first remission was the main contributor in transplantable patients and BR in non-transplantable. Regularly updated national guidelines may help in a timely adoption of new treatments, thus improving the results.PMID:34730885
Source: Croatian Medical Journal - November 3, 2021 Category: General Medicine Authors: Sandra Ba šić-Kinda Karla Mi šura Jakobac Jasminka Sin čić-Petričević Dajana Deak Marijo Vodanovi ć Marinka Jaki ć-Bubalo Zdravko Mitrovi ć Aron Grube šić Barbara Dreta Dubravka Županić Krmek Bo žena Coha Delfa Radi ć-Krišto Igor Aurer Source Type: research
Neutropenia following Rituximab in paediatric non-malignant diseases: case series and review of the literature
Singapore Med J. 2021 Nov 8. doi: 10.11622/smedj.2021188. Online ahead of print.NO ABSTRACTPMID:34749497 | DOI:10.11622/smedj.2021188
Source: Singapore Medical Journal - November 9, 2021 Category: General Medicine Authors: Zhi Rui Samuel Lim Kai Liang Teh Lena Das Thaschawee Arkachaisri Source Type: research
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
CONCLUSION: In the last decade, the outcome of newly diagnosed MCL patients improved. ASCT in the first remission was the main contributor in transplantable patients and BR in non-transplantable. Regularly updated national guidelines may help in a timely adoption of new treatments, thus improving the results.PMID:34730885
Source: Croatian Medical Journal - November 3, 2021 Category: General Medicine Authors: Sandra Ba šić-Kinda Karla Mi šura Jakobac Jasminka Sin čić-Petričević Dajana Deak Marijo Vodanovi ć Marinka Jaki ć-Bubalo Zdravko Mitrovi ć Aron Grube šić Barbara Dreta Dubravka Županić Krmek Bo žena Coha Delfa Radi ć-Krišto Igor Aurer Source Type: research
Neutropenia following Rituximab in paediatric non-malignant diseases: case series and review of the literature
Singapore Med J. 2021 Nov 8. doi: 10.11622/smedj.2021188. Online ahead of print.NO ABSTRACTPMID:34749497 | DOI:10.11622/smedj.2021188
Source: Singapore Medical Journal - November 9, 2021 Category: General Medicine Authors: Zhi Rui Samuel Lim Kai Liang Teh Lena Das Thaschawee Arkachaisri Source Type: research
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
CONCLUSION: In the last decade, the outcome of newly diagnosed MCL patients improved. ASCT in the first remission was the main contributor in transplantable patients and BR in non-transplantable. Regularly updated national guidelines may help in a timely adoption of new treatments, thus improving the results.PMID:34730885
Source: Croatian Medical Journal - November 3, 2021 Category: General Medicine Authors: Sandra Ba šić-Kinda Karla Mi šura Jakobac Jasminka Sin čić-Petričević Dajana Deak Marijo Vodanovi ć Marinka Jaki ć-Bubalo Zdravko Mitrovi ć Aron Grube šić Barbara Dreta Dubravka Županić Krmek Bo žena Coha Delfa Radi ć-Krišto Igor Aurer Source Type: research
Neutropenia following Rituximab in paediatric non-malignant diseases: case series and review of the literature
Singapore Med J. 2021 Nov 8. doi: 10.11622/smedj.2021188. Online ahead of print.NO ABSTRACTPMID:34749497 | DOI:10.11622/smedj.2021188
Source: Singapore Medical Journal - November 9, 2021 Category: General Medicine Authors: Zhi Rui Samuel Lim Kai Liang Teh Lena Das Thaschawee Arkachaisri Source Type: research
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
CONCLUSION: In the last decade, the outcome of newly diagnosed MCL patients improved. ASCT in the first remission was the main contributor in transplantable patients and BR in non-transplantable. Regularly updated national guidelines may help in a timely adoption of new treatments, thus improving the results.PMID:34730885
Source: Croatian Medical Journal - November 3, 2021 Category: General Medicine Authors: Sandra Ba šić-Kinda Karla Mi šura Jakobac Jasminka Sin čić-Petričević Dajana Deak Marijo Vodanovi ć Marinka Jaki ć-Bubalo Zdravko Mitrovi ć Aron Grube šić Barbara Dreta Dubravka Županić Krmek Bo žena Coha Delfa Radi ć-Krišto Igor Aurer Source Type: research
Neutropenia following Rituximab in paediatric non-malignant diseases: case series and review of the literature
Singapore Med J. 2021 Nov 8. doi: 10.11622/smedj.2021188. Online ahead of print.NO ABSTRACTPMID:34749497 | DOI:10.11622/smedj.2021188
Source: Singapore Medical Journal - November 9, 2021 Category: General Medicine Authors: Zhi Rui Samuel Lim Kai Liang Teh Lena Das Thaschawee Arkachaisri Source Type: research
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
CONCLUSION: In the last decade, the outcome of newly diagnosed MCL patients improved. ASCT in the first remission was the main contributor in transplantable patients and BR in non-transplantable. Regularly updated national guidelines may help in a timely adoption of new treatments, thus improving the results.PMID:34730885
Source: Croatian Medical Journal - November 3, 2021 Category: General Medicine Authors: Sandra Ba šić-Kinda Karla Mi šura Jakobac Jasminka Sin čić-Petričević Dajana Deak Marijo Vodanovi ć Marinka Jaki ć-Bubalo Zdravko Mitrovi ć Aron Grube šić Barbara Dreta Dubravka Županić Krmek Bo žena Coha Delfa Radi ć-Krišto Igor Aurer Source Type: research
Efficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM study
CONCLUSIONS: The results of this subgroup analysis were consistent with those of the global population, and they suggest that G-chemo has a positive benefit-risk profile in patients from China with FL.TRIAL REGISTRATION: ClinicalTrials.gov, No. NCT01332968.PMID:35194005 | DOI:10.1097/CM9.0000000000001737
Source: Chinese Medical Journal - February 23, 2022 Category: General Medicine Authors: Xiaonan Hong Yuqin Song Yuankai Shi Qingyuan Zhang Wei Guo Gang Wu Junmin Li Jifeng Feng Anastasiia Kinkolykh Andrea Knapp Tongyu Lin Source Type: research
